Insights

Strategic Partnerships CILCARE has active and high-profile collaboration momentum, including a Sanofi licensing deal with equity, indicating receptivity to co-development and strategic alliances that can accelerate market access and funding for joint auditory science programs.

US Expansion Recent investments and gateway initiatives aimed at the U.S. market, plus collaboration with Massachusetts General Hospital and presence at SelectUSA, suggest strong sales opportunities for US-based trials, regulatory navigation, and onshore partnerships.

Clinical Pipeline Lead candidate CIL001 and a portfolio centered on cochlear synaptopathy and auditory biomarkers present multiple entry points for pharma and biotech co-development, CRO services, and diagnostic-therapeutic integration opportunities.

Funding & Grants FEDER program laureate status signals access to European public funding and regional support, which can be leveraged to de-risk partnerships, co-funding for trials, and joint ventures in preventive auditory health.

Analytics & Preventive Health Auditory analytics initiatives to define digital hearing signatures open opportunities for data partnerships, digital health integration, and longitudinal monitoring solutions that complement traditional therapeutics and expand value propositions.

Similar companies to Cilcare

Cilcare Tech Stack

Cilcare uses 8 technology products and services including WordPress, CookieYes, Shopify, and more. Explore Cilcare's tech stack below.

  • Content Management System
  • Cookie Compliance
  • E-commerce
  • Underscore.js
    Javascript Libraries
  • OVHcloud
    Platform As A Service
  • MonsterInsights
    Web Platform Extensions
  • OceanWP
    Web Platform Extensions

Media & News

Cilcare's Email Address Formats

Cilcare uses at least 3 email formats:
Cilcare Email FormatsExamplePercentage
First.Last@cilcare.comJohn.Doe@cilcare.com
96%
FirstLast@cilcare.comJohnDoe@cilcare.com
2%
FLast@cilcare.comJDoe@cilcare.com
2%

Frequently Asked Questions

What is Cilcare's phone number?

Minus sign iconPlus sign icon
You can contact Cilcare's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cilcare's official website and social media links?

Minus sign iconPlus sign icon
Cilcare's official website is cilcare.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Cilcare generate?

Minus sign iconPlus sign icon
As of August 2026, Cilcare's annual revenue is estimated to be $1M - $10M.

What is Cilcare's SIC code and NAICS code?

Minus sign iconPlus sign icon
Cilcare's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cilcare have currently?

Minus sign iconPlus sign icon
As of August 2026, Cilcare has approximately 65 employees across 4 continents, including Europe, North America and Africa. Key team members include Chief Executive Officer: C. B., Cfo & Strategic Board Secretary: J. G. and Chief Operations Officer & Chief Scientific Officer: G. N. Explore Cilcare's employee directory with LeadIQ.

What industry does Cilcare belong to?

Minus sign iconPlus sign icon
Cilcare operates in the Biotechnology Research industry.

What technology does Cilcare use?

Minus sign iconPlus sign icon
Cilcare's tech stack includes WordPress, CookieYes, Shopify, Microsoft 365, Underscore.js, OVHcloud, MonsterInsights and OceanWP.

What is Cilcare's email format?

Minus sign iconPlus sign icon
Cilcare's email format typically follows the pattern of First.Last@cilcare.com. Find more Cilcare email formats with LeadIQ.

How much funding has Cilcare raised to date?

Minus sign iconPlus sign icon
As of August 2026, Cilcare has raised $42M in funding. The last funding round occurred on Dec 04, 2024 for $42M.

When was Cilcare founded?

Minus sign iconPlus sign icon
Cilcare was founded in 2014.
Cilcare logo

Cilcare

Biotechnology ResearchOccitanie, France51-200 Employees

CILCARE is a biotechnology research company focused on auditory science, aiming to advance early diagnosis and targeted treatment by treating hearing as a window into overall health. Its work spans external innovation for developing therapies to prevent and treat hearing-related conditions, therapeutic programs with proprietary drug candidates and co-developed initiatives, and auditory analytics designed to use patient hearing measurements to characterize various impairments and related pathologies with precision. The company targets healthcare and life-sciences partners seeking solutions for inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss, tinnitus, and related chronic conditions, positioning itself at the intersection of neuroscience, audiology, and preventive medicine. Based in Montpellier, France, CILCARE operates across multiple programs and collaborations, including clinical effort focused on a lead candidate advancing toward trials in partnership with Massachusetts General Hospital. Recent activities include initiatives to support foreign biotech entry into the U.S. market and participation in industry conferences and meetings that highlight its ongoing expansion and research in hearing-related health care.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $42M

    Cilcare has raised a total of $42M of funding over 1 rounds. Their latest funding round was raised on Dec 04, 2024 in the amount of $42M as a Series A.

  • $1M - $10M

    Cilcare's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.